Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
InnoCare Releases 2020 Annual Results and Business Highlights 2021-03-26 19:39
Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2021-03-26 16:00
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115 2021-03-26 08:38
Antengene Announces Financial Results for Full Year 2020 2021-03-26 08:00
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion 2021-03-26 08:00
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round 2021-03-26 05:19
Antengene Appoints Kevin Lynch as Chief Medical Officer 2021-03-25 23:26
Antengene Appoints Bo Shan as Chief Scientific Officer 2021-03-25 22:36
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020 2021-03-25 22:03
China Eastern Flies Vaccines to Dominican Republic 2021-03-25 19:22
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers 2021-03-25 18:29
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform 2021-03-25 17:00
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine 2021-03-25 17:00
Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility near Narita Airport 2021-03-25 15:00
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar 2021-03-24 23:27
Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation 2021-03-24 19:07
Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA 2021-03-24 12:25
CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients 2021-03-24 10:46
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial 2021-03-24 04:41
Dr. Cheng-Chi Chao joins ChemPartner as Vice President and Head of Immunotherapy and Inflammation 2021-03-24 00:02
1 252 253 254 255 256 412